Latest News and Press Releases
Want to stay updated on the latest news?
-
TORONTO, Aug. 18, 2016 (GLOBE NEWSWIRE) -- Profound Medical Corp. (“Profound” or the “Company”) (TSXV:PRN), an emerging medical device company focused on prostate cancer care, today reported...
-
TORONTO, Aug. 15, 2016 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSXV:PRN) (“Profound” or the “Company”), an emerging medical device company focused on prostate cancer care, today announced the...
-
TORONTO, Aug. 10, 2016 (GLOBE NEWSWIRE) -- Profound Medical Corp. (“Profound” or “Company”) (TSX-V:PRN), a medical device company commercializing a unique, MR-guided ablation procedure for prostate...
-
TORONTO, June 22, 2016 (GLOBE NEWSWIRE) -- Profound Medical Corp. (“Profound” or the “Company”) (TSXV:PRN) is pleased to announce the results of the votes on the matters considered at its...
-
Profound Medical Corp. and Philips Sell TULSA-PRO™ System to University Hospital of Cologne, Germany
TORONTO, June 21, 2016 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSXV:PRN) (“Profound” or the “Company”) an emerging medical device company focused on prostate care, today announced that it and...
-
TORONTO, June 20, 2016 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSXV:PRN) ("Profound" or "the Company"), an emerging medical device company focused on prostate care, today announced that it and...
-
TORONTO, June 07, 2016 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSXV:PRN) (“Profound” or the “Company”), an emerging medical device company focused on prostate care, hereby informs shareholders...
-
TORONTO, May 19, 2016 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX-V:PRN), an emerging medical device company focused on prostate care, today announced that it has been granted Investigational...
-
TORONTO and AMSTERDAM, Netherlands, May 11, 2016 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSXV:PRN), a Toronto-based medical device company and Royal Philips (NYSE:PHG) (AEX:PHIA), a leading...
-
TORONTO, May 06, 2016 (GLOBE NEWSWIRE) -- Profound Medical Corp. (“Profound” or “Company”) (TSXV:PRN), a medical device company commercializing a unique, MR guided ablation procedure for prostate...